Lolli, C., A. Verde, L. Degli Esposti, V. Acciai, A. Brigido, E. Proietti, and S. Scagliarini. “Cabozantinib Use in Second or Subsequent Line of Treatment in Renal Cell Carcinoma: An Analysis of Italian Administrative Databases”. Global and Regional Health Technology Assessment, vol. 11, no. 1, July 2024, pp. 154-60, doi:10.33393/grhta.2024.2892.